Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Principles of method if other than guideline:
Ten healthy rats (5/sex) were exposed nose-only to a test atmosphere of phthalic anhydride of 2.14 mg/L (highest technically feasible concentration) for 4 hours. The animals were observed for mortality, signs of gross toxicity, and behavioral changes at least once daily for 14 days following exposure or until death occurred. Body weights were recorded prior to exposure and again on Days 7 and 14 (termination) or after death. Necropsies were performed on all animals.
GLP compliance:
yes
Test type:
other: highest technically feasible concentration used

Test material

Constituent 1
Chemical structure
Reference substance name:
Phthalic anhydride
EC Number:
201-607-5
EC Name:
Phthalic anhydride
Cas Number:
85-44-9
Molecular formula:
C8H4O3
IUPAC Name:
1,3-dihydro-2-benzofuran-1,3-dione
Details on test material:
purtity: 99.9%

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose only
Vehicle:
other: unchanged (no vehicle)
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
2.14 mg/L
No. of animals per sex per dose:
5
Control animals:
no

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 2.14 mg/L air (analytical)
Based on:
test mat.
Exp. duration:
4 h

Any other information on results incl. tables

One male died upon chamber removal. There were no clinical signs noted for this animal prior to death. Following exposure, the clinical signs observed for the surviving animals included hypoactivity, abnormal respiration, reduced fecal volume, ocular discharge and facial and/or anogenital staining. However they recovered by Day 14. Although three animals lost weight by Day 7, all surviving animals gained body weight over the 14-day observation period. Gross necropsy of the decedent revealed discoloration of the lungs and liver. No gross abnormalities were noted for any of the euthanized animals when necropsied at the conclusion of the 14-day observation period.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The exact LC50 cannot be determined.
LC50 > 2.14 mg/L (aerosol) - highest technically feasible concentration.
Executive summary:

Method: according OECD 403 - ten healthy rats (5/sex) were exposed nose-only to a test atmosphere of phthalic anhydride of 2.14 mg/L (highest technically feasible concentration) for 4 hours.

Result: LC50 > 2.14 mg/L (aerosol) - following exposure, the clinical signs observed for the surviving animals included hypoactivity, abnormal respiration, reduced fecal volume, ocular discharge and facial and/or anogenital staining. However they recovered by Day 14. Although three animals lost weight by Day 7, all surviving animals gained body weight over the 14-day observation period. Gross necropsy of the decedent revealed discoloration of the lungs and liver. No gross abnormalities were noted for any of the euthanized animals when necropsied at the conclusion of the 14-day observation period.